Metraipolis › archive › dc_ee4acc742e0c

Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis — Europe PMC PMID:42824353

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42824353
DOI
10.3389/fphar.2026.1917719
License (as archived)
solo-consultazione
Archived
2026-10-07T21:57:27.698Z
SHA-256 of the archived text
c6bb75903cd33182bdeef5d61e95482edabd4432611f3e231b2c5934bdfdc060
Stable URL of this page
https://metraipolis.com/documento/dc_ee4acc742e0c

How to cite

Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis — Europe PMC PMID:42824353 — Europe PMC (en), https://europepmc.org/article/MED/42824353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee4acc742e0c (Metraipolis archive dc_ee4acc742e0c, sha256 c6bb75903cd33182bdeef5d61e95482edabd4432611f3e231b2c5934bdfdc060)
BibTeX
@misc{dcee4acc742e0c,
  title = {Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis — Europe PMC PMID:42824353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42824353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee4acc742e0c; sha256 c6bb75903cd33182bdeef5d61e95482edabd4432611f3e231b2c5934bdfdc060},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824353. Agents can read the archived copy with the MCP tool read_document.